Achelios Therapeutics   Report issue

For profit Phase 2
Founded: Chapel Hill NC United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2014
NCT02057315
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Achelios Therapeutics, Inc.